Leucadia National - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
Leucadia National ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,345,494
-5.7%
39,388
+6.3%
0.01%
-7.7%
Q2 2023$1,427,157
-38.1%
37,069
-42.4%
0.01%
-31.6%
Q1 2023$2,304,876
-30.3%
64,400
-23.2%
0.02%
-13.6%
Q4 2022$3,308,17783,9000.02%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders